Open Beta
TREN
MetriLume
TREN

US marketsCPIX

SEC-sourced researchBeta

CPIX

CUMBERLAND PHARMACEUTICALS INC

Company comparison ↗

Data passport

CIK
0001087294
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Sep 11, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 37,867,945.0000 USD; December 2025: 44,521,431.0000 USD44.5M USD0 USD0December 2024December 2025
CPIX · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202437,867,945.0000Mar 9, 2026
December 202544,521,431.0000Mar 9, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202544,521,431.0000-2,836,128.00004,932,522.000076,823,992.000052,279,770.0000Mar 9, 2026
December 202437,867,945.0000-6,479,770.0000-612,186.000075,583,410.000053,037,433.0000Mar 9, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$44.52MDecember 2025Mar 9, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$37.87MDecember 2024Mar 9, 202610-K
Net incomeNetIncomeLoss-$2.84MDecember 2025Mar 9, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$4.93MDecember 2025Mar 9, 202610-K
Total assetsAssets$76.82MDecember 2025Mar 9, 202610-K
Total liabilitiesLiabilities$52.28MDecember 2025Mar 9, 202610-K

New filings

Explore methodology ↗